NCT07017283

Brief Summary

This study aims to investigate the impact of deep analgosedation versus endotracheal intubation general anesthesia on perioperative sedation related adverse events in elderly ERCP patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
170

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 21, 2025

Completed
22 days until next milestone

First Posted

Study publicly available on registry

June 12, 2025

Completed
5 months until next milestone

Study Start

First participant enrolled

November 10, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2026

Completed
Last Updated

December 18, 2025

Status Verified

November 1, 2025

Enrollment Period

4 months

First QC Date

May 21, 2025

Last Update Submit

December 10, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Perioperative sedation related adverse events

    Perioperative period

Secondary Outcomes (11)

  • recovery room time

    Perioperative period

  • Nasopharyngeal airway requires face mask ventilation or switching to tracheal intubation

    Perioperative

  • Second intubation after the tracheal intubation is removed

    Perioperative

  • Tachycardia (>100 beats/minute) or bradycardia (<50 beats/minute)

    Perioperative

  • Rating of reflux degree

    perioperative

  • +6 more secondary outcomes

Study Arms (2)

General anesthesia

ACTIVE COMPARATOR
Device: Tracheal intubation general anesthesia

Deep sedation

EXPERIMENTAL
Device: Nasopharyngeal airway ventilation

Interventions

Endotracheal intubation with general anesthesia was administered to the patient during the ERCP procedure.

General anesthesia

Nasopharyngeal airway-assisted deep sedation was employed for the patient during the ERCP procedure.

Deep sedation

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 60 and above;
  • ASA physical status≤III;
  • Patients who scheduled for elective therapeutic ERCP (ERCP complexity grading system;
  • Willing to provide informed consent (or by legal guardian/witness if applicable).

You may not qualify if:

  • : Altered gastrointestinal anatomy, delayed gastric emptying, or gastric outlet obstruction; 2.Coagulopathy or epistaxis tendency; 3.Cardiac diseases (e.g., coronary artery disease, heart failure, arrhythmias); 4.Pulmonary diseases (e.g., asthma, COPD); 5.Prior hypersensitivity to anesthetic agents; 6.Active upper respiratory infection; 7.Severe liver and kidney diseases; 8.Difficult airway: Preoperative anesthesiologist assessment of difficult airway; 9.Psychiatric disorders, cognitive impairment, critical illness, or pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sir Run Run Shaw Hospital, Zhejiang University School of Medicine

Hangzhou, Zhijiang, 310016, China

RECRUITING

Related Publications (1)

  • Lv X, Xu Y, Sun J, Liu H, Yu Y, Chen G. Effect of deep analgosedation vs. intubated general anesthesia on perioperative sedation-related adverse events in older adults undergoing ERCP: protocol for a randomized controlled trial. Front Med (Lausanne). 2026 Feb 26;13:1764649. doi: 10.3389/fmed.2026.1764649. eCollection 2026.

MeSH Terms

Conditions

Pancreatic Diseases

Condition Hierarchy (Ancestors)

Digestive System Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
chief physician

Study Record Dates

First Submitted

May 21, 2025

First Posted

June 12, 2025

Study Start

November 10, 2025

Primary Completion

February 28, 2026

Study Completion

February 28, 2026

Last Updated

December 18, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL

Locations